# Hepatocellular Carcinoma Registry in Asia: The INSIGHT Registry

> **NCT03233360** · — · COMPLETED · sponsor: **National Cancer Centre, Singapore** · enrollment: 2533 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03233360
- **Lead sponsor:** National Cancer Centre, Singapore
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-17
- **Primary completion:** 2020-06-30
- **Final completion:** 2020-12-31
- **Target enrollment:** 2533 (ACTUAL)
- **Last updated:** 2022-12-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03233360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03233360, "Hepatocellular Carcinoma Registry in Asia: The INSIGHT Registry". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03233360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*